NeuroPace (NPCE) Income from Non-Controlling Interests (2020 - 2022)
NeuroPace's (NPCE) quarterly Income from Non-Controlling Interests came in at $226000.0 in Q4 2022, up 174.1% year-on-year from $82452.2 in Q4 2021, and up 93.16% quarter-over-quarter from $117000.0 in Q3 2022.
NeuroPace (NPCE) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends
NeuroPace's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $226000.0 for Q4 2022.
- On a quarterly basis, Income from Non-Controlling Interests rose 174.1% year-over-year to $226000.0 in Q4 2022; TTM through Sep 2023 was $226000.0, a 116.53% increase from a year earlier, with the FY2022 full-year figure at -$836000.0, down 174.1% from the prior year.
- Income from Non-Controlling Interests grew to $226000.0 in Q4 2022 per NPCE's latest filing, from $117000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $226000.0 in Q4 2022 and bottomed at -$710000.0 in Q1 2022.
- The 3-year median for Income from Non-Controlling Interests is $4000.0 (2020), against an average of -$100818.2.
- Across the five-year window, Income from Non-Controlling Interests surged 450.0% in 2021 and slumped 2031.82% in 2022, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $32000.0 in 2020, then sank by 1053.12% to -$305000.0 in 2021, then jumped by 174.1% to $226000.0 in 2022.
- Per Business Quant, the three latest NPCE Income from Non-Controlling Interests figures stand at $226000.0 (Q4 2022), $117000.0 (Q3 2022), and -$469000.0 (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -5.85 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 226,000.00 |
| Sep 30, 2022 | 117,000.00 |
| Jun 30, 2022 | -469,000.00 |
| Mar 31, 2022 | -710,000.00 |
| Dec 31, 2021 | -305,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | -22,000.00 |
| Dec 31, 2020 | 32,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 37,000.00 |
| Mar 31, 2020 | -41,000.00 |